Dicot AB enters research collaboration with Uppsala University and the W. Szafer Institute of Botany
Press release: Uppsala, May 31, 2022. Dicot AB is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile dysfunction and premature ejaculation. Dicot announces today that the company has entered a research collaboration with Uppsala University and the W. Szafer Institute of Botany of the Polish Academy of Sciences (PAS) to investigate a new technology to make starting material for production of the drug substance.Dicot is developing a novel potency drug aimed to be the first choice for the treatment of erectile dysfunction and premature ejaculation. The